iHuman (IH)
NYSE:IH
Want to see IH full AI Analyst Report?
Total Valuation
iHuman has a market cap or net worth of $87.17M. The enterprise value is -$1.02B.
Market Cap$87.17M
Enterprise Value-$1.02B
Share Statistics
iHuman has 22,544,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,544,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
iHuman’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.04%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)6.04%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.09M
Profits Per Employee128.36K
Employee Count723
Asset Turnover0.57
Inventory Turnover11.79
Valuation Ratios
The current PE Ratio of iHuman is 2.5. iHuman’s PEG ratio is -0.51.
PE Ratio2.5
PS Ratio0.19
PB Ratio0.15
Price to Fair Value0.15
Price to FCF3.34
Price to Operating Cash Flow0.00
PEG Ratio-0.51
Income Statement
In the last 12 months, iHuman had revenue of 785.03M and earned 92.80M in profits. Earnings per share was 9.10.
Revenue785.03M
Gross Profit532.69M
Operating Income64.94M
Pretax Income99.02M
Net Income92.80M
EBITDA64.94M
Earnings Per Share (EPS)9.10
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
iHuman pays an annual dividend of $0.085, resulting in a dividend yield of 3.93%
Dividend Per Share$0.085
Dividend Yield3.93%
Payout Ratio29.51%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change-12.32%
50-Day Moving Average1.72
200-Day Moving Average2.28
Relative Strength Index (RSI)53.16
Average Volume (3m)17.50K
Important Dates
iHuman upcoming earnings date is Jun 24, 2026, Before Open (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateJun 24, 2026
Ex-Dividend Date―
Financial Position
iHuman as a current ratio of 3.57, with Debt / Equity ratio of 1.14%
Current Ratio3.57
Quick Ratio3.51
Debt to Market Cap0.01
Net Debt to EBITDA-17.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, iHuman has paid 6.21M in taxes.
Income Tax6.21M
Effective Tax Rate0.06
Enterprise Valuation
iHuman EV to EBITDA ratio is -15.24, with an EV/FCF ratio of -21.92.
EV to Sales-1.26
EV to EBITDA-15.24
EV to Free Cash Flow-21.92
EV to Operating Cash Flow-19.82
Balance Sheet
iHuman has $1.10B in cash and marketable securities with $12.28M in debt, giving a net cash position of $1.09B billion.
Cash & Marketable Securities$1.10B
Total Debt$12.28M
Net Cash$1.09B
Net Cash Per Share$48.25
Tangible Book Value Per Share$95.16
Margins
Gross margin is 67.86%, with operating margin of 8.27%, and net profit margin of 11.82%.
Gross Margin67.86%
Operating Margin8.27%
Pretax Margin12.61%
Net Profit Margin11.82%
EBITDA Margin8.27%
EBIT Margin8.27%
Analyst Forecast
The average price target for iHuman is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-12.43%
EPS Growth Forecast-1.57%